Ursodeoxycholic acid switches oxaliplatin‐induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53‐caspase 8 pathway in HepG2 hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cancer

• Publication date

  2009-09-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ijc.24853PMID 19728331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Repression of NF‐κB and activation of AP‐1 enhance apoptosis in prostate cancer cells

  2009cited by this paper
• Ursodeoxycholic Acid Suppresses Cox-2 Expression in Colon Cancer: Roles of Ras, p38, and CCAAT/Enhancer-Binding Protein

  2008cited by this paper
• Molecular mechanisms and pathophysiology of necrotic cell death.

  2008cited by this paper
• Prognostic Role of Tumor Necrosis, Microvessel Density, Vascular Endothelial Growth Factor and Hypoxia Inducible Factor-1α in Patients with Clear Cell Renal Carcinoma after Radical Nephrectomy in a Long Term Follow-up

  2008cited by this paper
• Inflammation: gearing the journey to cancer.

  2008cited by this paper
• Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.

  2008cited by this paper
• The inflammatory response to cell death.

  2008cited by this paper
• Japanese encephalitis virus infection activates caspase-8 and -9 in a FADD-independent and mitochondrion-dependent manner.

  2008cited by this paper
• Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.

  2007cited by this paper
• Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

  2007cited by this paper
• Ursodeoxycholic Acid versus Sulfasalazine in Colitis-Related Colon Carcinogenesis in Mice

  2007cited by this paper
• Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

  2007cited by this paper
• Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

  2007cited by this paper
• Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.

  2007cited by this paper
• Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study

  2007cited by this paper
• Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

  2007cited by this paper
• Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small‐duct primary sclerosing cholangitis

  2007cited by this paper
• Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid.

  2007cited by this paper
• Protein kinase C‐ERK1/2 signal pathway switches glucose depletion‐induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells

  2007cited by this paper
• Inflammation, a Key Event in Cancer Development

  2006cited by this paper
• Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones

  2006cited by this paper
• Necrosis is associated with IL-6 production but apoptosis is not.

  2006cited by this paper
• Enhancement of DNA topoisomerase I inhibitor–induced apoptosis by ursodeoxycholic acid

  2006cited by this paper
• Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.

  2006cited by this paper
• -Dependent Cytoprotective Effects of Ursodeoxycholic and Tauroursodeoxycholic Acid on the Biliary Epithelium in a Rat Model of Cholestasis and Loss of Bile Ducts

  2006cited by this paper
• Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

  2006cited by this paper
• Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.

  2006cited by this paper
• Prevention of colitis‐associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid

  2006cited by this paper
• Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid‐induced activation of NF‐κB and AP‐1 in human colon cancer cells

  2006cited by this paper
• Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma.

  2005cited by this paper
• Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

  2005cited by this paper
• Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

  2005influential reference
• Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

  2005cited by this paper
• Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma

  2004cited by this paper
• Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

  2004cited by this paper
• Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.

  2004cited by this paper
• Postoperative jaundice.

  2004cited by this paper
• A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation

  2004cited by this paper
• Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.

  2004cited by this paper
• Inflammation and necrosis promote tumour growth

  2004cited by this paper
• Hepatocellular carcinoma: present status and future prospects.

  2003cited by this paper
• Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.

  2003cited by this paper
• Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma.

  2003cited by this paper
• Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells

  2002cited by this paper
• Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.

  2002cited by this paper
• Editorial: Looking Beyond the Obvious

  2002cited by this paper
• Mortality from hepatocellular and biliary cancers: changing epidemiological trends

  2002cited by this paper
• Use of ursodeoxycholic acid in patients with liver disease

  2002cited by this paper
• Inhibition of the MAPK and PI3K pathways enhances UDCA‐induced apoptosis in primary rodent hepatocytes

  2002cited by this paper
• Cellular and molecular pharmacology of oxaliplatin.

  2002cited by this paper
• Ursodeoxycholic acid diminishes Fas‐ligand–induced apoptosis in mouse hepatocytes

  2002cited by this paper
• Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States

  2001cited by this paper
• Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.

  2001cited by this paper
• The role of bile acids in carcinogenesis.

  2001cited by this paper
• 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.

  2001cited by this paper
• Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver.

  2001cited by this paper
• Ursodeoxycholic Acid Suppresses Extent of Lipid Peroxidation in Diseased Liver in Experimental Cholestatic Liver Disease

  2000cited by this paper
• Oxaliplatin: a review of its use in the management of metastatic colorectal cancer.

  1999cited by this paper
• Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation

  1999cited by this paper
• A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis.

  1999cited by this paper
• More than one way to die: apoptosis, necrosis and reactive oxygen damage

  1999cited by this paper
• Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines.

  1999influential reference
• Review article: overview of medical treatments in unresectable hepatocellular carcinoma—an impossible meta‐analysis?

  1998cited by this paper
• Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials.

  1997cited by this paper
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.

  1996cited by this paper
• Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.

  1994cited by this paper
• Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].

  1993cited by this paper
• Apoptosis and necrosis. Basic types and mechanisms of cell death.

  1993cited by this paper
• Molecular aspects of membrane stabilization by ursodeoxycholate

  1993cited by this paper
• Postoperative Jaundice

  1988cited by this paper
• Selective inactivation of lactate dehydrogenase of rat tissues by sodium deoxycholate.

  1979cited by this paper
• Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction.

  1972cited by this paper

• Ursodeoxycholic acid ameliorates paclitaxel-induced hepatic injury in rats: Evaluation of oxidative and DNA damage, apoptosis and autophagy.

  2025cites this paper
• AMX0035 Mitigates Oligodendrocyte Apoptosis and Ameliorates Demyelination in MCAO Rats by Inhibiting Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

  2025cites this paper
• Plasma metabolites associated with endometriosis in adolescents and young adults.

  2025cites this paper
• Carcinogenic and anticancer activities of microbiota-derived secondary bile acids

  2025cites this paper
• Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy

  2025cites this paper
• Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma

  2025cites this paper
• The Effect of Resistance Training on Serum Levels of Lipid Profile and Liver Enzymes in Male Rat Undergoing Radiotherapy

  2025cites this paper
• Utidelone induces mechanical and cold allodynia in mice via TRPA1 activation

  2025cites this paper
• Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress

  2025cites this paper
• Protective effects of Boswellia and Curcuma extract on oxaliplatin-induced neuropathy via modulation of NF-κB signaling

  2024cites this paper
• UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis

  2024cites this paper
• The anticancer activity of bile acids in drug discovery and development

  2024cites this paper
• Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

  2024cites this paper
• Hepatoprotective effects of phytochemicals and plant extracts against chemotherapy-induced liver damage in animal models: a systematic review

  2024influential citation
• Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models

  2024cites this paper
• Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects

  2024cites this paper
• Naringin and naringenin counteract taxol-induced liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation

  2023cites this paper
• Development on Animal Models for Drug/Chemical Induced Liver Injury

  2023cites this paper
• Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer.

  2023cites this paper
• The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies

  2023cites this paper
• Dietary EPA+DHA Mitigate Hepatic Toxicity and Modify the Oxylipin Profile in an Animal Model of Colorectal Cancer Treated with Chemotherapy

  2022cites this paper
• Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives

  2022cites this paper
• The role of bile acids in carcinogenesis

  2022cites this paper
• Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems

  2021cites this paper
• Anticancer Effects of Ursi Fel Extract and Its Active Compound, Ursodeoxycholic Acid, in FRO Anaplastic Thyroid Cancer Cells

  2021cites this paper
• Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC

  2021cites this paper
• Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

  2021cites this paper
• Selenium Safeguards the Liver Against 5-Fluorouracil Induced Toxicity

  2020cites this paper
• Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment

  2020cites this paper
• Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS

  2020influential citation
• Short-term adverse effects of anticancer drugs in patients with type 2 diabetes

  2019cites this paper
• Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity

  2019cites this paper
• High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases

  2019cites this paper
• CMAR_A_201341 7111..7122

  2019cites this paper
• Coenzyme Q10 and resveratrol abrogate paclitaxel-induced hepatotoxicity in rats

  2019cites this paper
• Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy.

  2019cites this paper
• Extracellular acidity enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis via DR5 in gastric cancer cells

  2018cites this paper
• GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells

  2018cites this paper
• Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells

  2018cites this paper
• To Be Or Not to Be: the “Smoker’s Paradox” – An in-Vitro Study

  2018cites this paper
• Evaluation of Liver injury from Cisplatin-based Chemotherapy in Patient with Nasopharyngeal Cancer

  2018cites this paper
• Bile Acids and Viral Hepatitis and Hepatocellular Carcinoma

  2017cites this paper
• Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation

  2017cites this paper
• Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth

  2017cites this paper
• Bile Acids and Cancer: Direct and Environmental-Dependent Effects.

  2017cites this paper
• Antiinflammatory and Hepatoprotective Medicinal Herbs as Potential Substitutes for Bear Bile.

  2017cites this paper
• Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB.

  2017cites this paper
• Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells

  2017cites this paper
• Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy

  2016cites this paper
• Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin

  2016cites this paper
• Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting

  2016cites this paper
• Estudi de l'efecte de la curcumina en la reversió de la resistència adquirida a oxaliplatí mitjançant la inhibició de la via de senyalització de NF-kB en models cel·lulars de càncer colorectal

  2016cites this paper
• Title Substitutes for Bear Bile for the Treatment of Liver Diseases : Research Progress and Future Perspective

  2016cites this paper
• Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linked via amino acids as anti-cancer agents

  2016cites this paper
• Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response

  2016influential citation
• Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective

  2016cites this paper
• Include mushroom in daily diet—A strategy for better hepatic health

  2016cites this paper
• Oxaliplatin triggers necrosis as well as apoptosis in gastric cancer SGC-7901 cells.

  2015cites this paper
• Oxaliplatin Induced Suicidal Death of Human Erythrocytes

  2015cites this paper
• Animal models of hepatotoxicity

  2015cites this paper
• Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy.

  2015cites this paper
• Knockdown of Glutamate Cysteine Ligase Catalytic Subunit by siRNA Causes the Gold Nanoparticles-Induced Cytotoxicity in Lung Cancer Cells

  2015cites this paper
• Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

  2015cites this paper
• Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

  2015cites this paper
• The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy.

  2015cites this paper
• Shining light on cell death processes – a novel biosensor for necroptosis, a newly described cell death program

  2014cites this paper
• The Actions of Ursodeoxycholic Acid and its derivatives on Colonic Epithelial Transport and Barrier Function

  2014cites this paper
• Discovery of protein biomarker predictive for the response to FOLFOX therapy in colorectal cancer

  2014cites this paper
• Reactive oxygen species generation is essential for cisplatininduced accelerated senescence in hepatocellular carcinoma

  2014cites this paper
• Rôle de la caspase-1 dans les phénomènes de mort cellulaire dans le cancer colorectal

  2014cites this paper
• Characterization of the DNA methylation patterns of chemosensitive and chemoresistant human cancer cells: Biological and clinical impact

  2014cites this paper
• Flow cytometry analysis of cancer cell death induced by the extract of Thai plant Ellipeiopsis cherrevensis.

  2013cites this paper
• The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

  2013cites this paper
• Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.

  2013cites this paper
• Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer.

  2013cites this paper
• Silencing of Pokemon Enhances Caspase-Dependent Apoptosis via Fas- and Mitochondria-Mediated Pathways in Hepatocellular Carcinoma Cells

  2013cites this paper
• Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy

  2013cites this paper
• Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.

  2012cites this paper
• Carbocisteine Reduces the Cytotoxicity of Oxaliplatin

  2012cites this paper
• Mitochondrial dysfunction induced impairment of spermatogenesis in LPS-treated rats: modulatory role of lycopene.

  2012cites this paper
• Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin

  2012cites this paper
• Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies

  2012cites this paper
• Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue.

  2011cites this paper
• Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.

  2011cites this paper
• Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation

  2011influential citation
• Orientadora: Maria Alexandra Núncio de Carvalho Ramos Fernandes, Professora Doutora, FCT/UNL Co-orientadora: Susana Isabel Rodrigues dos Santos, Professora Doutora, IST/UTL

  2011cites this paper
• Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo

  2011cites this paper
• Investigation of the mechanism of action of ursodeoxycholic acid on normal or inflamed epithelia in vivo and on the intestinal epithelial cells in vitro

  2011cites this paper
• Chemical and biological analysis of active free and conjugated bile acids in animal bile using HPLC-ELSD and MTT methods.

  2011cites this paper
• Genotoxicity of metal ions: chemical insights.

  2010cites this paper
• TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer

  2010cites this paper
• Chemotherapy-Associated Liver Injury: Impact on Surgical Management of Colorectal Cancer Liver Metastases

  2010cites this paper